OnCore Login

Return to Trial Database

HCRN-GU93-1

A Phase III Study of Vinblastine vs Vinblastine plus Estramustine for Metastatic Hormone Refractory Prostatic Cancer

Status

Study Completed

Cancer Type(s)

Prostate

Study Contact

Publications

Improved Survival for Patients with Hormone-Refractory Prostate Cancer Receiving Estramustine-Based Antimicrotubule Therapy
  • G Hudes, E Ross, B Roth, A Balsham, P Loehrer, H Ramsey, J Sprandio, M Entmacher, W Dugan, R Ansari, L Einhorn
A Phase III Trial of Vinblastine Versus Vinblastine plus Estramustine Phosphate for Metastatic Hormone-refractory Prostate Cancer (HRPC)
  • G Hudes, B Roth, P Loehrer, H Ramsey, J Sprandio, M Entmacher, W Dugan, R Ansari, F Monaco, M Hanna, L Einhorn

Trial Locations

All sites in which the trial HCRN-GU93-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278